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Prolonged Enteroviral Infection in a Patient Who Developed Pericarditis and 
Heart Failure After Bone Marrow Transplantation
Joep M. D. Calama, Nicole de Leeuw, 
Shulamiet W itteboi, Herman Peters, 
and W illem  J. G. Melchers
From the Institutes o f  Medical Microbiology and Pathology, and the
Department o f  Hematolog)>, University Hospital Nijmegen,
Nijmegen, the Netherlands
We describe a patient who developed heart failure and pericarditis after bone marrow transplanta­
tion for a hematologic malignancy. The patient died of heart failure complicated by pneumonia. 
Despite extensive surveillance, an infectious cause for the heart failure was not found while he was 
alive. In addition, cultures of specimens obtained at autopsy did not reveal a cause for the heart 
failure. Enterovirus was detected by the polymerase chain reaction (PCR) in two samples of pleural 
fluid that were obtained 21 days apart while he was alive. After the patient died, enteroviral RNA 
was also detected in his lungs, liver, and spleen, indicating a generalized infection. Analysis of the 
PCR products revealed sequences sharing close homology with the coxsackie B-like group of 
enteroviruses. In addition to reporting this case, we review the literature regarding enteroviral 
infections after transplantation.
Viral infections occur frequently after bone marrow trans- therapy with chlorambucil, bleomycin, vincristine, and predni-
plantation (BMT) and are an important cause of morbidity and sone was initiated because progression of the disease was sus-
mortality. The main group of viruses that are responsible for pected. In December 1992, a major partial remission was 
infection after BMT are the herpesviruses, which may either achieved.
be transmitted by the graft or cause a clinically manifest reacti- The patient received a conditioning regimen that consisted
vation of infection [1]. Enteroviruses, which comprise the po- of carmustine, cyclophosphamide, and etoposide before under-
liovinises, coxsackie viruses, and echo viruses, have seldom 
been reported to cause severe infections after transplantation.
Herein, we describe a patient with heart failure and pericarditis 
that developed after he underwent BMT. No virus could be profloxacin (2.5 g/d), oral acyclovir (400 mg q.i.d.), and am- 
cultured, but enteroviral RNA was found in his pleural fluid, photericin B lozenges (10 mg q.i.d.). Six days later a pleural
going BMT. Autologous bone marrow was reinfused on 21 
January 1993. On this day, a prophylactic regimen was started 
with oral co-trimoxazole (1,920 mg twice weekly), oral ci-
lungs, liver, and spleen with use of PCR.
Case Report
A 22-year-old man was admitted to the hospital for autolo­
gous BMT. His medical history was remarkable for Hodgkin’s
rub was heard, but findings on a repeated radiograph were 
unchanged in comparison to those on a radiograph obtained 
15 days earlier on admission. On day 10, fever (temperature, 
>39°C) developed, and therapy with iv ceftazidime (2 g t.i.d., 
the agent routinely administered under such circumstances) 
was started. Blood cultures yielded Staphylococcus haemolyti-
disease (stage IIIB), which was diagnosed in 1990 and partially cus, and therapy with iv teicoplanin (starting dose of 800 mg
to chemotherapy with MOPP (mechlorethamine, on the first day, 400 mg/d thereafter) was instituted; later, iv
vincristine, procarbazine, and prednisone). A complete remis- vancomycin (500 mg q.i.d.) was administered because his fever
sion was achieved only after he underwent total nodal irradia­
tion. The disease recurred within 1 year, and the patient was
persisted. A pleural effusion developed, from which S. haemo- 
lyticus was also isolated. Therefore, iv rifampin (600 mg/d)
referred to our hospital. Second-line chemotherapy with M- was added to the antibiotic regimen. At the same time, treat- 
CAVe-CEC (methotrexate, cyclophosphamide, Adriamycin ment with iv fluconazole (200 mg/d) was started because Can-
[doxorubicin], vinblastine, carmustine, etoposide, chlorambu­
cil) was started in March 1992 but was interrupted because of 
a febrile episode that was associated with anemia, thrombocyto­
penia, and a pleural effusion of unknown origin. Third-line
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dida albicans was isolated from his mouth.
Eighteen days after undergoing BMT, the patient developed 
heart failure due to pericarditis with pleural effusion. Repeated 
cultures of pleural fluid samples (for bacteria, fungi, and vi­
ruses) remained negative. The pericardial fluid was cultured 
only for bacteria and fungi, and the results were also negative. 
Treatment consisted of antibiotics (iv vancomycin, rifampin, 
and ceftazidime and oral fluconazole [150 mg/d]) and gradual 
dehydration because of persistent exudative pericarditis and
Microbiology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nij- pleural effusion. From day 40 until day 53 after BMT, intrave-
megen, the Netherlands. nous prednisone (60 mg/d) was added to the regimen for man-
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needed frequent-thrombocyte transfusions because he devel- nian laryngeal carcinoma) cells. Cultures were maintained for 
oped hemorrhagic cystitis as a com plication ol the high dose 4 weeks. Isolates from cultures of stool and cultures of autopsy 
of cyclophosphamide he had received d u rin g  conditioning. Re- samples were blindly repassaged after 2 weeks. CMV cultures 
constitution of the bone marrow (neutrophils in blood, >0.5 were performed in shell vials and read after 48 hours by means 
X 10 /L) was achieved on day 49 a fte r  BMT. of immunofluorescence with a monoclonal antibody to early
On day 47, therapy with all intravenous antibiotics was dis- antigen. For detection of enterovirus, mice (a single litter of 
continued. Because of the patient’s im paired  immune status, 1-day-old Swiss outbred mice) were inoculated by combined 
prophylactic therapy with oral ciprofloxacin and acyclovir was intracerebral and intraperitoneal injection of samples, as de­
continued. His clinical condition tem porarily  improved, but on scribed by Melnick et al. [4]. The mice were killed after 14 
day 59 after BMT, a low-grade fever re tu rned , and his condition days; homogenized samples of their brains and torsos were
inoculated into a second litter whose brains and torsos were 
also tested for enterovirus by means of PCR.
PCR. Primers were selected in the 5' nontranslated region,
deteriorated. All bacterial cultures perfo rm ed  during this febrile 
episode remained negative. On 28 M arch  1993,91 
undergoing BMT, the patient died o f  respiratory failure.
At autopsy, bilateral pleural effusions and pulmonary edema which is highly conserved among entero vims es. The primers, 
were observed. Fibrinous, proliferative, hemorrhagic pericardi- the extraction of RNA, reverse transcription, and the PCRs
heart have been described before [5], Samples were run in duplicate.
weight. Terminal cardiomyopathy w as diagnosed by means of RNA and cDNA from coxsackievirus B3 (Nancy strain) were
an enzymatic reaction that revealed a  diffuse loss of lactate 
dehydrogenase from myocardial tissue. Furthermore, ascites,
used as positive controls. Distilled water was tested in duplicate 
as a negative control. A PCR with /3-actin primers was used
marked atrophy of the adrenal glands, a n d  severe hemorrhagic as an internal control for the quality of the RNA extracted from
urocystitis were present. Permission to  autopsy the CNS was the specimens. PCR testing was also performed for detection
denied by the patient’s family.
Microscopic examination of the m yocardium  showed local 
fibrosis. A small inflammatory infiltrate consisting of lympho-
of encephalomyocarditis virus and M. pneumoniae [6, 7]. A 
positive finding was confirmed by repeating the PCR, starting 
with the original clinical sample. Standard precautions to avoid
cytes was found in the left ventricle. A  partly resolving, partly contamination were followed [8]. The PCR product was di­
organizing pneumonia was observed o n  histopathologic exami- rectly sequenced using the AmpliCycle sequencing kit ac-
nation of the lungs, and Lactobacillus jensen ii was recovered cording to the instructions of the manufacturer (Perkin & El-
from a culture of lung tissue. Iron d ep o sits  were seen in the mer, Roche Molecular Systems, Branchburg, NJ). DNA 
liver and spleen. The bone marrow w a s  nonnocellular as well sequence alignment studies were perfonned, with use of the 
as normocytic, with marked siderosis. There were no signs of European Molecular Biology Laboratory database (Heidelberg,
recurrence of Hodgkin’s disease. Viral cultures were negative. 
We concluded that respiratory failure w a s  the cause of death.
Germany) and the sequence analysis software package of the 
Genetics Computer Group of the University of Wisconsin im­
plemented on a VAX computer.
Laboratory Methods
Serology. Before undergoing transplantation, the patient 
was routinely screened for antibodies to  hepatitis B virus and
Results
Routine screening tests for hepatitis vimses and HIV were
hepatitis C virus, HIV, cytomegalovirus (CMV), herpes sim- negative. Our patient had antibodies to the different herpesvi- 
plex virus 1 and herpes simplex virus 2 , varicella-zoster virus, ruses, but there was no evidence of an active infection at the
Toxoplasma lì (by ELISA), an d  Epstein-Barr virus (by time he underwent BMT (serologies for IgM and IgA antibod-
. After th e  onset of his pleural ies were negative). He had no antibodies to T. gondii. Serolo
symptoms, CF tests were performed to  detect antibodies to gies for respiratory pathogens, enteroviruses, and CMV were 
adenoviruses; respiratory syncytial v iru s ;  influenza virus A and performed on days 13, 19, 33, 48, and 63 after BMT. High 
influenza virus B; coronaviruses; parainfluenza virus 1, para- titers or significant rises in titers were not observed. CF titers
influenza virus 2, and parainfluenza virus 3; enteroviruses; of antibodies to entero vimses ranged between 1:8 and 1:16 for
CMV; Mycoplasma pneumoniae; C hlam ydia  psittaci; and Cox- all samples. ELIS As were negative for IgA and IgM antibodies
iella burnetii. In addition, ELISAs fo r  IgG, IgM, and IgA and showed no increases in IgG antibody levels. Repeated
antibodies to enterovirus [2], CMV, a n d  M. pneumoniae were attempts to isolate viruses from the patient’s throat, stool, and
pleural fluid yielded negative results, and repeated buffy-coat
Isolation o f vimses. On days 12, 9 , 6, and 2 before BMT cultures for CMV were also negative. In addition, viral cultures
and on days 1, 5, 8, and 12 after B M T , throat washings were of autopsy specimens from the heart, spleen, liver, and lungs
routinely cultured for vimses; thereafter, viral cultures were remained negative (table 1).
performed when an infection was c lin ically  suspected. Virus PCRs with enterovirus-specific primers performed on pleu-
isolation was performed on human em bryonal lung fibroblasts, ral-fluid samples obtained on days 12 and 33 after BMT were 
tertiary cynomolgus monkey kidney ce lls  [31, and Hep-2 (hu- positive, with consistent results for all duplicate reactions. The
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Table 1. Detection of enterovirus in a patient who developed peri- results of repeated testing were the same. Enterovirus-specific
RNA was detected by PCR in autopsy specimens of the lungs,carditis and heart failure after bone marrow transplantation.
Method used for detection*
No. of days after 
transplantation Specimen tested
Mouse
inoculation
PCR o f
specimen 
from patient
1 Throat washings ND ND
5 Throat washings ND ND
8 Throat washings ND ND
12 Throat washings ND ND
12 Pleural fluid H-
35 Feces ND ND
19 Buffy coat ND ND
33 Pleural fluid — +
38 Feces ND ND
64 Buffy coat ND ND
67 Lung _ r|^
Liver — 4 *
Spleen — "H
Myocardium —
NOTE. ND =  not done. +  =  enterovirus (or enterovirus RNA) detected; 
— =  no enterovirus detected.
* Tissue cultures o f all samples were all negative (the buffy coat was cultured 
only for cytomegalovirus).
and
M
ß
pies. Because of the discrepancy between PCR results and the 
results of viral cultures, samples were inoculated in newborn 
mice in an attempt to isolate an enterovirus (table 1). None of 
the mice became ill or died, and PCR results for samples from 
killed mice (brains and torsos) were negative.
The enterovirus-specific PCR product in the 5' nontranslated 
region was sequenced, and the sequence was aligned to all 
enteroviral sequences available (figure 1). The PCR fragment 
had a sequence that showed the closest homology with coxsack­
ievirus B3 (table 2), indicating that the virus belongs to the 
coxsackie B -like group of enteroviruses.
Discussion
Our patient developed heart failure after undergoing BMT. 
Enterovirus was detected in several organs by PCR but not by 
culture. However, enterovirus was not found in his heart; this 
may be due to a sampling error [9]. The heart failure might 
have been secondary to persistent pericarditis with effusion or 
to the extensive irradiation and chemotherapy given for induc­
ing remission of Hodgkin’s disease. Nevertheless, detection of
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Figure 1. Homology between sequences of enterovirus detected in a patient (PAT) and known sequences of coxsackieviruses A and B (CA 
and CB), echo viruses (EV)> swine vesicular disease virus (SVDV), and polioviruses (PV). A total of 153 nucleotides were compared. The 
patient developed pericarditis and heart failure after bone marrow transplantation.
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Table 2. Percentage o f  hom ology  betw een the sequence o f  the pa­
tient’s virus and know n sequences o f  enteroviruses.
Patient
Coxsackievirus B3 (CB3)
Echovirus 6 (EV6)
Echovirus 12 (EV12)
Coxsackievirus B4 (CB4)
Echovirus 2 (EV2)
Echovirus 9 (EV9)
Echovirus 25 (EV25)
Swine vesicular disea.se vims (SVDV) 
Echovirus 4 (EV4)
Coxsackievirus B5 (CB5) 
Coxsackievirus A l 6 (CAI6)
Poliovirus 2 (PV2)
Echovirus 11 (EV 1I )
100.0
91.6
91.4
90.2
90.2
89.5 
89.0
88.9
88.9
88.2 
88.2
87.6
87.6 
86.3
NOTE. See figure 1 lor sequences of the enteroviruses.
role in the severity of these infections. In our patient, no evi­
dence of active CMV infection was found.
Isolation of enteroviruses can be difficult in some cases. 
Enteroviral RNA has been detected in culture-negative samples 
of CSF during both acute episodes of meningoencephalitis as 
well as chronic episodes of the infection [20, 21]. Clinical 
observations with regard to agammaglobulinémie patients sup­
port the fact that this is not an uncommon problem [13]. It 
may be that in such patients, the virus is at least partially 
neutralized by antibody present in the gamma globulins that 
are administered. Our patient did not receive gamma globulin 
preparations. However, he did receive frequent transfusions of 
RBCs and platelets. Between days 36 and 50 after BMT, 13 
units of plasma were also given. These blood products may 
have contained antibodies that hampered isolation of the virus. 
Another explanation may be that some enteroviruses fail to 
grow in the cell lines and mice that are routinely used for 
isolation.
viral RNA in several organs (the spleen, liver, and lungs) im- Finally, it has been reported that enteroviral RNA can be 
plies that the infection was generalized. A serological response detected in patients with chronic diseases such as dilated car 
to enterovirus infection was not observed; this lack of response diomyopathy, postpoliomyelitis syndrome, polymyositis, and 
might be due to delayed recovery of lymphocyte function [1]. chronic fatigue syndrome in the absence of positive viral cul- 
On the other hand, these enterovirus-specific tests are based tures. It has been suggested that enteroviral RNA can persist 
on cross-reactive serological responses and inherently lack sen- in patients with these chronic medical conditions, but the per- 
sitivity. By using both a CF test and ELISA, we can detect sistence of the virus is still a matter of debate [22, 23]. We 
70%-80% of acute enteroviral infections caused by a variety believe that our patient had an active infection from which he 
of serotypes [2]. was unable to recover because of impaired immunity.
The other pathogens that were isolated during the course of The case described in this paper confirms the fact that entero- 
our patient’s illness or at autopsy could not have caused his viruses may cause prolonged infections in patients who undergo 
heart failure. After the sepsis due to S. haemolyticus was BMT. Although the repeated finding of enteroviral RNA as the 
treated, bacterial cultures of pleural fluid, pericardial fluid, and sole positive result suggests that there was a causal relationship 
blood samples obtained while he was alive were consistently between our patient’s pericarditis and heart failure and the 
negative. L. jenscnii was the only organism recovered after he virus, this was not formally proven. However, this finding con- 
died. Lactobacillus species sometimes cause endocarditis [10]; firms that enteroviral infections may remain undiagnosed un- 
however, there were no signs of endocarditis in our patient, less molecular techniques are applied, 
and L. jenscnii was isolated only from his lungs.
Enteroviruses, particularly the coxsackie B viruses, are im­
portant causes of pericarditis and myocarditis. In healthy individu­
als, such complications usually have a benign course [11]. In
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